Ukraine’s Cabinet Expands ‘Affordable Medicines’ Program from July 1: New Drug Categories to Be Added
The Ukrainian government has announced a significant expansion of its ‘Affordable Medicines’ program, set to take effect on July 1st. The Cabinet of Ministers will add 51 international nonproprietary names (INNs) to the existing list of subsidized medications, marking one of the largest expansions since the program’s inception. This development is expected to benefit millions of Ukrainians who rely on government assistance to access essential medications for chronic conditions and acute health needs.
The ‘Affordable Medicines’ program, known in Ukrainian as ‘Dostupni Liky,’ has been a cornerstone of Ukraine’s healthcare reform efforts since its launch in April 2017. The initiative allows patients to receive certain medications either free of charge or with a small co-payment at participating pharmacies across the country. Doctors issue electronic prescriptions through the eHealth system, and patients can then obtain their medications at any pharmacy enrolled in the program. Over the years, the program has helped reduce the financial burden on Ukrainian families, particularly those managing chronic illnesses such as cardiovascular disease, diabetes, and asthma.
The expansion comes at a critical time for Ukraine’s healthcare system, which continues to operate under challenging wartime conditions. Despite the ongoing conflict, the government has prioritized maintaining and even expanding access to essential medications. Health officials have emphasized that the addition of 51 new INNs represents a comprehensive approach to addressing gaps in the current medication coverage. International nonproprietary names refer to the official, generic names of pharmaceutical substances, meaning that multiple branded versions of each medication may become available under the program, giving patients more choices and potentially improving supply stability.
Healthcare experts have noted that expanding the list of covered medications is essential for addressing the changing health needs of the Ukrainian population. The stress and trauma associated with the ongoing war have led to increased rates of mental health conditions, cardiovascular problems, and other stress-related illnesses. Additionally, the displacement of millions of Ukrainians, both internally and abroad, has complicated access to regular medical care and prescription medications. By broadening the scope of the ‘Affordable Medicines’ program, the government aims to ensure that vulnerable populations can continue to receive necessary treatments regardless of their circumstances.
The program operates through a reimbursement mechanism where the National Health Service of Ukraine (NHSU) compensates pharmacies for dispensed medications. Since its launch, the initiative has covered primarily cardiovascular medications, drugs for type 2 diabetes, and bronchial asthma treatments – conditions that affect a substantial portion of Ukraine’s population. According to previous government data, cardiovascular diseases remain the leading cause of death in Ukraine, making access to affordable heart medications a public health priority. The expansion is expected to include additional therapeutic categories, though specific details about which drug groups will be added have yet to be fully disclosed.
The electronic prescription system, integrated with Ukraine’s broader eHealth infrastructure, has been instrumental in the program’s success. Patients can now track their prescriptions through mobile applications and receive notifications when their medications are ready for pickup. This digitalization has not only improved convenience but also helped combat prescription fraud and ensure that medications reach those who genuinely need them. The system has processed millions of prescriptions since its implementation, demonstrating both its scalability and reliability even under wartime pressures.
Looking ahead, Ukrainian health officials have indicated that further expansions of the ‘Affordable Medicines’ program may be considered based on epidemiological data and public health priorities. International partners, including the World Health Organization and various European health agencies, have provided technical assistance and funding support to strengthen Ukraine’s pharmaceutical supply chains. As the country continues to navigate the challenges of war while pursuing European integration, programs like ‘Dostupni Liky’ represent a commitment to maintaining healthcare standards and protecting the well-being of Ukrainian citizens. The July 1st expansion marks another step in this ongoing effort to make essential medications accessible to all who need them.